Mmp12 deficiency attenuated AAA development allied with reduced macrophage recruitment in the peri-aortic CaCl2-application model (122), and a mouse model of combined Ang II-infusion and TGF-β neutralising antibody treatment (66). The gene discussed is MMP12; the disease is triple-A syndrome.